Cargando…
Hepatic arterial embolization in patients with neuroendocrine tumors
Liver metastases occur in 46-93% of patients with neuroendocrine neoplasms (NENs). Presence and extension of liver metastases are considered important prognostic factors, as they may significantly impair the patient’s quality of life, because of either tumor bulk or hormonal hypersecretion. Therapie...
Autores principales: | Del Prete, Michela, Fiore, Francesco, Modica, Roberta, Marotta, Vincenzo, Marciello, Francesca, Ramundo, Valeria, Di Sarno, Antonella, Carratù, Annachiara, di Roseto, Chiara de Luca, Tafuto, Salvatore, Tatangelo, Fabiana, Baldelli, Robero, Colao, Annamaria, Faggiano, Antongiulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038067/ https://www.ncbi.nlm.nih.gov/pubmed/24887262 http://dx.doi.org/10.1186/1756-9966-33-43 |
Ejemplares similares
-
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
por: Altieri, Barbara, et al.
Publicado: (2020) -
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms
por: Tafuto, Salvatore, et al.
Publicado: (2019) -
Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life
por: Faggiano, Antongiulio, et al.
Publicado: (2015) -
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1
por: Circelli, Luisa, et al.
Publicado: (2015) -
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)